Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Z-LEHD-FMK (TFA)

Z-LEHD-FMK TFA is a selective and irreversible inhibitor of caspase-9, protects against lethal reperfusion injury and attenuates apoptosis. Z-LEHD-FMK TFA exhibits the neuroprotective effect in a rat model of spinal cord trauma[1][2][3].

Product Specifications

CAS Number

524746-03-0

UNSPSC

12352209

Target

Apoptosis; Caspase

Type

Peptides

Related Pathways

Apoptosis

Applications

COVID-19-immunoregulation

Field of Research

Cancer; Neurological Disease

Assay Protocol

https://www.medchemexpress.com/z-lehd-fmk-tfa.html

Solubility

H2O

Smiles

OC(C(F)(F)F)=O.O=C(OCC1=CC=CC=C1)N[C@@H](CC(C)C)C(N[C@@H](CCC(OC)=O)C(N[C@H](C(N[C@H](C(CF)=O)CC(OC)=O)=O)CC2=CN=CN2)=O)=O

Molecular Formula

C34H44F4N6O12

Molecular Weight

804.74

References & Citations

[1]Ozoren N, et, al. The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res. 2000 Nov 15; 60 (22) : 6259-65.|[2]Colak A, et, al. Neuroprotection and functional recovery after application of the caspase-9 inhibitor z-LEHD-fmk in a rat model of traumatic spinal cord injury. J Neurosurg Spine. 2005 Mar; 2 (3) : 327-34.|[3]Mocanu MM, et, al. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury. Br J Pharmacol. 2000 May; 130 (2) : 197-200.

Shipping Conditions

Room temperature

Scientific Category

Peptides

Clinical Information

No Development Reported

Isoform

Caspase 9

Citation 01

MSphere. 2024 May 17:e0023624.|Preprints. 2024 Aug 14.|Virol Sin. 2024 May 30:S1995-820X (24) 00078-6.|Cell Mol Life Sci. 2025 Nov 19;82 (1) :408.|Cell Rep. 2025 Mar 25;44 (4) :115462.|Chem Biol Interact. 2025 Oct 22:420:111693.|Food Chem Toxicol. 2018 Oct:120:143-154.|Food Chem Toxicol. 2019 Oct:132:110655.|Food Chem Toxicol. 2020 Dec;146:111843.|Infect Immun. 2025 Aug 12;93 (8) :e0015825.|J Cell Mol Med. 2019 Apr;23 (4) :2489-2504.|J Cell Mol Med. 2020 Jul;24 (14) :8151-8165.|Oxid Med Cell Longev. 2022 Jun 26:2022:2912276.|Sci Adv. 2023 Oct 6;9 (40) :eadi6586.|SSRN. 2025 Oct 15.

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF740 conjugate, 0.1mg/mL
BNC740679-100 1x 100 µL

CD171 / L1CAM (L1 Cell Adhesion Molecule) (UJ127), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL
BNC472853-100 1x 100 µL

CD54 / ICAM-1 (15.2), CF647 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD4 (EDU-2), CF488A conjugate, 0.1mg/mL
BNC880345-500 1x 500 µL

CD4 (EDU-2), CF488A conjugate, 0.1mg/mL

Sign In for Pricing
View Details
CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL
BNC742853-500 1x 500 µL

CD54 / ICAM-1 (15.2), CF740 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
MART-1 / Melan-A (M2-7C10), CF568 conjugate, 0.1mg/mL
BNC680009-500 1x 500 µL

MART-1 / Melan-A (M2-7C10), CF568 conjugate, 0.1mg/mL

Sign In for Pricing
View Details
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL
BNC041820-500 1x 500 µL

Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), CF405S conjugate, 0.1mg/mL

Sign In for Pricing
View Details